Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-23

Clinical Trial Update: Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravenous iron supplementation to prevent postoperative delirium after hip fracture surgery; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intravenous iron supplementation

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Hip Fractures | Phase 4 | Status: UNKNOWN